Abstract. In the search for new diagnostic methods that would distinguish Trypanosoma brucei rhodesiense from T. b. brucei and T. b. gambiense, we have developed two polymerase chain reaction (PCR) primer sets. The first primer set was derived from the serum resistance−associated (SRA) gene of T. b. rhodesiense that confers resistance to lysis by normal human serum (NHS). The specificity of the SRA-based PCR was tested on 97 different trypanosome populations originating from various taxonomic groups, host species, and geographic regions. Only one of 25 T. b. rhodesiense samples was negative in this PCR, and none of 72 other samples were positive in this assay. Interestingly, a reference T. brucei strain (TREU927/4) currently used for genome sequencing was negative for the SRA gene; however, this strain was resistant to lysis by NHS. The second primer set was derived from a specific variant surface glycoprotein (VSG) expression site where the SRA gene is expressed (R-ES). This primer set identified the strain as T. b. rhodesiense in 17 of 17 SRA gene-positive strains in which it was tested. These data strongly suggest that expression of the SRA gene is generally involved in resistance to lysis by NHS in T. b. rhodesiense strains.
INTRODUCTION
Trypanosoma brucei gambiense and T. b. rhodesiense are the causative agents of human African trypanosomiasis (sleeping sickness). While T. b. gambiense is localized to west and central Africa and is responsible for chronic human sleeping sickness, T. b. rhodesiense is present in eastern Africa and causes an acute form of the disease. A related parasite, T. b. brucei, can infect a wide variety of mammals, but not humans, and is distributed throughout the entire African tsetse fly region. 1 According to a recent estimation from the World Health Organization, 50 million people in Africa are at risk of acquiring sleeping sickness; the actual number of cases varies from 300,000 to 500,000. 2 Routine diagnosis of human and animal infections is usually based on recognition of clinical manifestations and the detection of parasites by microscopy. 2 For infections with T. b. gambiense, diagnosis is performed with an antibody detection test (the card agglutination test for trypanosomiasis [CATT)]), which is subsequently verified by light microscopy. 3, 4 Extensive molecular and biochemical analysis have indicated that while T. b. gambiense isolates are homogeneous over most of their wide geographic distribution, T. b. rhodesiense isolates are heterogeneous, showing high genotypic variation within and between different disease foci. [5] [6] [7] [8] [9] Various analytical methods such as isoenzyme analysis and restriction fragment length polymorphism (RFLP) have revealed great heterogeneity in both T. b. rhodesiense and T. b. brucei, but have not defined clear criteria for differentiation between these two subspecies. Therefore, new genetic tools are required to discriminate between trypanosomes within the animal reservoirs and the insect vector, and between those that infect humans and those that are not infectious.
A breakthrough in this field was obtained when it was observed that a single T. b. rhodesiense gene, the serum resistance-associated (SRA) gene, was necessary to confer resistance to lysis by normal human serum (NHS). [10] [11] [12] This gene is transcribed from one of the multiple telomeric loci where the variant surface glycoprotein (VSG) genes are expressed (VSG expression sites). This particular expression site (ES), known as R-ES, is selected when trypanosomes are grown in the presence of NHS. 12 Apart from the presence of SRA, the R-ES is also characterized by a deletion due to homologous recombination between 70-base pair (bp) repeats, resulting in a characteristic array of these repeats upstream from the SRA gene. 12 In this study, SRA-and R-ES-derived oligonucleotide sequences were used as primers for a polymerase chain reaction (PCR) to identify T. b. rhodesiense within a collection of 97 different trypanosomes populations of various taxonomic groups, hosts, and geographic origins. These primers were shown to be specific for T. b. rhodesiense. Moreover, the systematic detection of DNA fragments characteristic for the R-ES, as well as evidence of SRA transcripts in NHS-resistant strains of this subspecies, strongly suggest that expression of the SRA gene is associated with a particular R-ES that is involved in resistance to NHS in T. b. rhodesiense. However, exceptions may exist since the T. brucei reference strain (TREU927/4) currently used for genome sequencing was found to be SRA negative, but resistant to lysis by NHS. 6, 8 All trypanosomes were stored as cryostabilates in liquid nitrogen. Bloodstream form trypanosomes were first grown in OF1 mice (Iffa Credo, Charles River, Brussels, Belgium) and subsequently in Wistar rats (Harlan, Horst, The Netherlands). The parasites were isolated from blood samples using a DE52 column (Whatman, Newton, MA) according to the method of Lanham and Godfrey. 13 The eluted parasites were centrifuged at 1,200 × g for 30 minutes at 2°C. The pellet was then washed two times with 38 mM Na 2 HPO 4 , 2 mM NaH 2 PO4, 29 mM NaCl, 83 mM glucose, pH 8. Procyclic forms were grown in Cunningham culture medium or in a kit for in vitro isolation.
MATERIALS AND METHODS

Trypanosomes
14 These procyclic forms were purified from the culture media by centrifugation at 1,200 × g for 30 minutes at 2°C. The pellet was then washed two times with 38 mM Na 2 HPO 4 , 2 mM NaHPO 4 , 29 mM NaCl, 83 mM glucose, 100 mM sucrose, pH 8. All trypanosome pellets were stored at −70°C.
Normal human serum incubation infectivity test. The human serum resistance/sensitive phenotype was analyzed using the assay previously described.
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Extraction of DNA from parasites. Extraction of DNA from purified trypanosomes was performed as follows. Twenty microliters of purified trypanosome sediment (2 × 10 7 cells) were resuspended in 200 L of 8.1 mM Na 2 HPO4, 1.4 mM NaH 2 PO4, 140 mM NaCl, pH 7.4, and the trypanosome DNA was extracted using the Qiamp blood DNA mini kit (Qiagen, Valencia, CA). The DNA was eluted in 200 L of AE buffer (Qiagen). The typical DNA yield was 30 g/ml of eluate. For extraction of Plasmodium falciparum DNA, parasite-infected mouse blood was first treated for five minutes with the same volume of red blood cell lysing buffer (20 mM Tris-HCl, 140 mM NH 4 Cl, pH 7.2). The DNA was subse- ‡A ‫ס‬ E. quently extracted from a volume of 180 L using the Qiamp blood DNA extraction kit. The DNA was eluted in 200 L of AE buffer. The typical DNA yield was 20 g/ml of eluate. For extraction of Leishmania donovani DNA, parasites were harvested from Tobie's blood agar medium and centrifuged at 5,000 × g for five minutes at room temperature. The DNA was extracted using the Qiamp blood DNA extraction kit. Polymerase chain reactions. Primers were derived from the sequence of the SRA gene (GeneBank accession number Z37159). Using the GenBank homology search program, we designed primers that targeted a region showing no similarity with known DNA sequences. 11 The forward (5Ј-ATAGTGA-CAAGATGCGTACTCAACGC-3Ј) and reverse (5Ј-AAT-GTGTTCGAGTACTTCGGTCACGCT-3Ј) primers were constructed to amplify a 284-bp fragment between nucleotides 383 and 667 of the SRA gene.
Two other primers were designed based on the specific sequence of the VSG ES, (R-ES) where the SRA gene is transcribed in T. b. rhodesiense strain ETaR1. 12 As shown in Figure 1 , in the R-ES region these forward (5Ј-GTGGCG-GCAGCAAAAGTATCATC-3Ј) and reverse (5Ј-ACACTC-CAACACTCTCCTATC-3Ј) primers should amplify four fragments ranging in size from 290 bp to 530 bp.
All PCRs were performed using 10 ng of the DNA extracted from purified parasites. The DNA templates were amplified in 50 L of PCR mixture containing 1× PCR buffer (20 mM Tris-HCl, pH 8.7, 100 mM KCl, 50 mM (NH 4 ) 2 SO 4 , 1.5 mM MgCl 2 , 200 M of each of the four dNTPs, 1 M of each primer, and 2.5 units of HotStar Taq DNA polymerase [Qiagen] ). The PCR amplifications were conducted in a T3 Thermocycler (Biometra, Göttingen, Germany). The SRA gene-based PCR conditions were as follows: incubation for 15 min at 95°C, followed by 35 cycles of one minute at 94°C, one minute at 68°C, and one minute at 72°C, and a final extension for 10 minutes at 72°C. A 20-L sample of each PCR product was analyzed by electrophoresis in a 2% agarose gel. The gels were stained with ethidium bromide (1 g/ml) (Sigma, St. Louis, MO) and analyzed on an Imagemaster Video Detection System (Pharmacia, Piscataway, NJ). As a negative control, a PCR mixture without DNA template was included with the other samples.
Northern blot analysis. Total RNA was extracted from trypanosomes purified from blood on a DE52 column using the TriPure isolation reagent (F. Hoffman-La Roche, Basel, Switzerland) following the manufacturer's instructions. Northern blot analysis was performed as previously described. 12 Specificity of the R-ES-based PCR. Seventeen SRA genepositive strains tested for the presence of R-ES showed the expected pattern for this site. Moreover, 11 of 15 SRA genepositive, experimentally confirmed NHS-resistant strains were analyzed and found to be positive for SRA gene transcripts, whereas the remaining four SRA gene-positive, NHSsensitive strains did not show these transcripts (Table 1) . Two strains showed results that varied from this trend. Strain STIB884, a human isolate, was both SRA gene-negative and NHS-sensitive, which casts doubt on its identification as T. b. rhodesiense. Strain TREU927/4, which is currently used as a reference T. brucei strain for the trypanosome genomesequencing project (TIGR database), was SRA gene-negative and SRA transcript-negative. However, despite the absence of the SRA gene, the genome of this strain contains many SRA-related sequences, and this strain was confirmed to be resistant to lysis by NHS, although at a lower efficiency.
RESULTS
Specificity
DISCUSSION
Resistance to lysis by NHS is an important parameter used to distinguish T. b. brucei from the human infective subspecies T. b. rhodesiense and T. b. gambiense. In a given strain of the former subspecies, this characteristic could be attributed to the expression of SRA, a gene present within the polycistronic transcription units of one of the multiple VSG expression sites. 12, 16 In this study, we have evaluated the SRA gene as a tool for identification of T. b. rhodesiense by a PCR. A collection of 97 different trypanosome strains from various taxonomic groups, hosts, and geographic origins was screened. We included 25 different T. b. rhodesiense strains that were isolated from distinct foci such as Busoga and Tororo in southeastern Uganda, Lambwe Valley in Kenya, and Kagera Park in Rwanda. The SRA gene-based PCR was specific for T. b. rhodesiense. A 284-bp specific PCR product was generated in 24 of the 25 T. b. rhodesiense strains tested, whereas this fragment was never detected in other subspecies and species. Only one T. b. rhodesiense strain (STIB884) was SRA gene-negative by the PCR, but since it was also sensitive to lysis by NHS, this finding casts doubt on its identification as T. b. rhodesiense.
Other recently used analytical techniques such as isoenzyme analysis and RFLP failed to identify an unequivocal criteria that could differentiate T. b. rhodesiense from T. b. brucei. 5, 7, 17 Since a large variety wild and domestic animals serve as reservoirs for both subspecies, our PCR test could be used in the identification of trypanosomes that can infect humans and those that are not infective within the animal reservoir and the vector population. 21 The overlap in distribution of both of these pathogenic subspecies may result in erroneous diagnoses since both trypanosome subspecies are morphologically identical, and currently serologic methods have low specificity. However, since these subspecies show differential drug sensitivity, a correct differential diagnosis between T. b. gambiense and T. b. rhodesiense is essential for successful drug treatment of those with African trypanosomiasis. 4, 7 Therefore, the development of a simple molecular technique such as the SRA gene-based PCR may be essential in the correct identification of T. b. rhodesiense. The recently developed T. b. gambiense-specific PCR test based on the use of the T. gambiense-specific glycoprotein gene can also facilitate the correct diagnosis of both parasites that cause sleeping sickness. 22, 23 Since the VSG gene sequences of T. brucei show high mutation rates, this can hamper their use in diagnostic and epidemiologic studies. 24 Indeed, the use of the AnTat 11.17 and LiTat 1.3 (CATT antigen) VSG sequences in identifying T. b. gambiense showed that these genes and their products, although present in most strains, may be missing in some isolates from northwestern Uganda and Cameroon. 25, 26 Since the SRA gene resembles VSG genes and the extent of genetic evolution of this gene is currently unknown, one cannot exclude the existence of SRA gene-deficient T. b. rhodesiense parasites or the existence of parasites with a modified SRA gene. Only two SRA genes have been characterized that differ from each other by a few point mutations. 11, 27 Moreover, in all cases where this was studied, the SRA gene appears to be a member of a large gene family that contains many pseudogenes; thus, the possibility exists that none of these sequences are functional. 11, 12 The data presented here sug-gest that expression of the SRA gene is linked to resistance to NHS in T. b. rhodesiense, since the known site for SRA gene expression, R-ES, was detected in all T. b. rhodesiense strains tested, and SRA gene transcripts were detected in 11 of 15 SRA gene-positive, NHS-resistant parasites tested. Therefore, it appears that expression of the SRA gene is the mechanism used by T. b. rhodesiense to infect humans. This conclusion is consistent with the results of a recent field study in Uganda. 28 However, we observed an interesting finding with strain TREU927/4, which is currently used as a reference T. brucei strain for genome sequencing. This strain was found to be resistant to lysis by NHS without expression of the SRA gene, even though SRA gene-related sequences are present. Thus, future studies involving large collections of field isolates are needed to confirm the reliability of the SRA gene PCRs in identifying T. b. rhodesiense as the causative agent of human trypanosomiasis in different parasite foci.
